65 assets in Metastatic Malignant Neoplasm In The Colon

Therapeutic assets addressing Metastatic Malignant Neoplasm In The Colon, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Irinotecan Metastatic Malignant Neoplasm In The Colon	Oncolytics Biotech	P4	BB (68)
Adriamycin Metastatic Malignant Neoplasm In The Colon	Northwell Health	P4	B (63)
Durvalumab Metastatic Malignant Neoplasm In The Colon	University of Iowa	P2	B (61)
Immunoglobulin G2, Anti-(Human Ctla-4 (Antigen)) (Human Monoclonal Cp-675206 Clone 11.2.1 Heavy Chain) Disulphide With Human Monoclonal Cp-675206 Clone 11.2.1 Light Chain, Dimer Metastatic Malignant Neoplasm In The Colon	Centre Georges Francois Leclerc	P2	B (61)
Vemurafenib Metastatic Malignant Neoplasm In The Colon	Fudan University	P3	B (58)
Ipilimumab Metastatic Malignant Neoplasm In The Colon	GERCOR - Multidisciplinary Oncology Cooperative Group	P2	B (56)
Toripalimab Metastatic Malignant Neoplasm In The Colon	China Medical University, China	P2	B (56)
Tinzaparin Metastatic Malignant Neoplasm In The Colon	Galician Research Group on Digestive Tumors	P3	CCC (54)
Celecoxib Metastatic Malignant Neoplasm In The Colon	HaEmek Medical Center, Israel	P2	CCC (53)
Folic Acid Metastatic Malignant Neoplasm In The Colon	Liaoning Cancer Hospital & Institute	P2	CCC (53)
Pelareorep Metastatic Malignant Neoplasm In The Colon	Oncolytics Biotech	P2	CCC (53)
Retinol Metastatic Malignant Neoplasm In The Colon	Liaoning Cancer Hospital & Institute	P2	CCC (53)
Vandazole Metastatic Malignant Neoplasm In The Colon	Liaoning Cancer Hospital & Institute	P2	CCC (53)
Adebrelimab Metastatic Malignant Neoplasm In The Colon	Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.	P2	CCC (52)
Balstilimab Metastatic Malignant Neoplasm In The Colon	Darren Sigal, MD	P2	CCC (52)
Botensilimab Metastatic Malignant Neoplasm In The Colon	Darren Sigal, MD	P2	CCC (52)
Serplulimab Metastatic Malignant Neoplasm In The Colon	Shanghai Henlius Biotech	P2	CCC (52)
Tucidinostat Metastatic Malignant Neoplasm In The Colon	Feng Wang	P2	CCC (52)
Tunlametinib Metastatic Malignant Neoplasm In The Colon	Shanghai Kechow Pharma, Inc.	P3	CCC (52)
Sirexatamab Metastatic Malignant Neoplasm In The Colon	Leap Therapeutics, Inc.	P2	CCC (51)
Retifanlimab Metastatic Malignant Neoplasm In The Colon	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	P1/2	CCC (49)
Agen1423 Metastatic Malignant Neoplasm In The Colon	Weill Medical College of Cornell University	P2	CCC (48)
Agent-797 Metastatic Malignant Neoplasm In The Colon	Darren Sigal, MD	P2	CCC (48)
Anisodamine Metastatic Malignant Neoplasm In The Colon	Sun Yat-sen University	P2	CCC (48)
bp102 Metastatic Malignant Neoplasm In The Colon	Fudan University	P2	CCC (48)
Decitabine Metastatic Malignant Neoplasm In The Colon	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	P2	CCC (48)
hlx26 Metastatic Malignant Neoplasm In The Colon	Shanghai Henlius Biotech	P2	CCC (48)
Hrs-2189 Metastatic Malignant Neoplasm In The Colon	Fudan University	P2	CCC (48)
Isunakinra Metastatic Malignant Neoplasm In The Colon	Buzzard Pharmaceuticals	P2	CCC (48)
Lubiprostone Metastatic Malignant Neoplasm In The Colon	Sun Yat-sen University	P2	CCC (48)
Polypepi1018 Metastatic Malignant Neoplasm In The Colon	Treos Bio Limited	P2	CCC (48)
Retlirafusp Alfa Metastatic Malignant Neoplasm In The Colon	Fudan University	P2	CCC (48)
shr2554 Metastatic Malignant Neoplasm In The Colon	Fudan University	P2	CCC (48)
tl938 capsules Metastatic Malignant Neoplasm In The Colon	Suzhou Teligene Ltd.	P2	CCC (48)
Trifluorouracil Tepidopyrimidine Metastatic Malignant Neoplasm In The Colon	Sun Yat-sen University	P2	CCC (48)
Methotrexate Metastatic Malignant Neoplasm In The Colon	HaEmek Medical Center, Israel	P2	CC (45)
Valproic Acid Metastatic Malignant Neoplasm In The Colon	National Cancer Institute, Naples	P2	CC (45)
Fosifloxuridine Nafalbenamide Metastatic Malignant Neoplasm In The Colon	NuCana plc	P2	CC (42)
a2b530 Metastatic Malignant Neoplasm In The Colon	A2 Biotherapeutics Inc.	P1/2	CC (41)
Abt-301 Metastatic Malignant Neoplasm In The Colon	Anbogen Therapeutics, Inc.	P1/2	CC (41)
Avutometinib Metastatic Malignant Neoplasm In The Colon	University of Chicago	P1/2	CC (41)
CNA3103 (LGR5-targeted, Autologous CAR-T Cells) Metastatic Malignant Neoplasm In The Colon	Carina Biotech Limited	P1/2	CC (41)
Eb-Duo-Car-Nk-Cea/Gcc Metastatic Malignant Neoplasm In The Colon	Beijing Biotech	P1/2	CC (41)
eo4010 Metastatic Malignant Neoplasm In The Colon	Enterome	P1/2	CC (41)
Galunisertib Metastatic Malignant Neoplasm In The Colon	The Netherlands Cancer Institute	P1/2	CC (41)
hdm2017 Metastatic Malignant Neoplasm In The Colon	Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.	P1/2	CC (41)
xnw27011 Metastatic Malignant Neoplasm In The Colon	Evopoint Biosciences Inc.	P1/2	CC (41)
Obinutuzumab Metastatic Malignant Neoplasm In The Colon	NeoTX Therapeutics Ltd.	P1	CC (40)
18f-αvβ6-bp Metastatic Malignant Neoplasm In The Colon	Julie L. Sutcliffe, Ph.D	Early P1	C (39)
Atx-559 Metastatic Malignant Neoplasm In The Colon	Accent Therapeutics	P1	C (37)

Showing 1 to 50 of 65 assets

PreviousPage 1 of 2Next